NET Patient Foundation Research Abstracts
NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in England using English cancer registry data, with an aim to also access Scottish, Welsh and Northern Irish cancer registry data to also get UK wide statistics.
We carried out four pieces of research in 2017, abstracts for which can be found below:
- The Incidence and Prevalence of Neuroendocrine Tumours in England.
- The 1- year survival rates for Neuroendocrine tumour patients in England.
- Metachronus primary cancers in Neuroendocrine tumour patients.
- Neuroendocrine Tumour patients experiences of support in the community setting across the treatment trajectory.
Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic Neuroendocrine tumours
Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme
Self-reported side effects in neuroendocrine tumour (NET) patients prescribed somatostatin analogues – the role for specialist dietitians and nurses
- Assess what symptoms/side effects patients report on SSA’s.
- Assess the severity of symptoms/side effects reported by patients whilst on SSA’s.
- Produce recommendations on how to deal with symptoms commonly experienced by patients on SSA’s.
This study has been accepted to be published in the British Journal of Nursing.
Recent News
Neuroendocrine Cancer – The ‘Good’ Cancer
- "Neuroendocrine Cancer... Oh, that's a good cancer to have!" Let's talk about something that might initially sound a bit puzzling – being told you have a "good cancer." We know it might seem like a contradiction in terms, but for many diagnosed with neuroendocrine...
“Not Just NE Cancer” Podcast Recognised among Top 40 Cancer Podcasts
- We are thrilled to announce that Neuroendocrine Cancer UK's podcast, "Not Just NE Cancer," has achieved a remarkable milestone by being recognised as one of the Top 40 Cancer Podcasts by Feedspot, a content discovery platform. This recognition underscores our...
Neuroendocrine Cancer UK Launches Practice-Changing Grants
Neuroendocrine Cancer UK is thrilled to announce the launch of our Practice-Changing Grants initiative, which is part of our Advancing Research campaign. The grants are designed to identify practical solutions that significantly enhance the well-being and experiences...